Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 375-380

  Akiba, Hisaya ^a,b   Miyahira, Yasushi ^a   Atsuta, Machiko ^a,b   Takeda, Kazuyoshi ^a,b   Nohara, Chiyoko ^a   Futagawa, Toshiro ^a   Matsuda, Hironori ^a   Aoki, Takashi ^a   Yagita, Hideo ^a,b   Okumura, Ko ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Costimulation; Experimental leishmaniasis; OX40 OX40 ligand; Th1 Th2 differentiation; TNF TNF receptor family

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; LIGAND; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; DISEASE COURSE; FLOW CYTOMETRY; IMMUNOGLOBULIN BLOOD LEVEL; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

4-1BB LIGAND; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, CD30; ANTIGENS, CD70; CD30 LIGAND; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LIGANDS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 0034677124     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.375     Document Type: Article

References (30)

1. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:275-283.
2. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
3. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959-962.
4. Gruss, H.J., and S.K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Biol. 85:3378-3404.
5. Sugita, K., Y. Torimoto, Y. Nojima, J.F. Daley, S.F. Schlossman, and C. Morimoto. 1991. The 1A4 molecule (CD27) is involved in T cell activation. J. Immunol. 147:1477-1483.
6. + T cells producing Th2-type cytokines. FASEB J. 9:81-86.
7. Kim, Y.J., S.H. Kim, P. Mantel, and U.S. Kwon. 1998. Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses. Eur. J. Immunol. 28:881-890.
8. Ohshima, Y., L.P. Yang, T. Uchiyama, Y. Tanaka, P. Baum, M. Sergerie, P. Hermann, and G. Delespesse. 1998. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4 (+) T cells into high IL-4-producing effectors. Blood. 92:3338-3345.
9. Flynn, S., K.M. Toellner, C. Raykundalia. M. Goodall, and P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188:297-304.
10. Reiner, S.L., and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
11. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367-1371.
12. + T cell response. J. Exp. Med. 181:961-971.
13. Chatelain, R., K. Varkila, and R.L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infccted mice. J. Immunol. 148:1182-1187.
14. Kopf, M., F. Brombacher, G. Kohler, G. Kienzle, K.H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136.
15. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura. 1999. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:7058-7066.
16. Oshima, H., H. Nakano, C. Nohara, T. Kobata, A. Nakajima, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, T. Muto, H. Yagita, et al. 1998. Characterization of murine CD70 by molecular cloning and mAb. Int. Immunol. 10:517-526.
17. Shimozato, O., K. Takeda, H. Yagita, and K. Okumura. 1999. Expression of CD30 ligand (CD153) on murine activated T cells. Biochem. Biophys. Res. Commun. 256:519-526.
18. Kayagaki, N., A. Kawasaki, T. Ebata. H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777-1783.
19. Crowley, M., K. Inaba, M. Witmer-Pack, and R.M. Steinman. 1989. The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell. Immunol. 118:108-125.
20. Al-Shamkhani, A., M.L. Birkeland, M. Puklavec, M.H. Brown, W. James, and A.N. Barclay. 1996. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 26: 1695-1699.
21. Azuma, M., T. Hirano, H. Miyajima, N. Watanabe, H. Yagita, S. Enomoto, S. Furusawa, Z. Ovary, T. Kinashi, T. Honjo, et al. 1987. Regulation of murine IgE production in SJA/9 and nude mice. Potentiation of IgE production by recombinant interleukin 4. J. Immunol. 139:2538-2544.
22. Will, A., C. Blank, M. Rollinghoff, and H. Moll. 1992. Murine epidermal Langerhans cells are potent stimulators of an antigen-specific T cell response to Leishmania major, the cause of cutaneous leishmaniasis. Eur. J. Immunol. 22:1341-1347.
23. Brown, J.A., R.G. Titus, N. Nabavi, and L.H. Glimcher. 1996. Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J. Infect. Dis. 174: 1303-1308.
24. Brown, D.R., J.M. Green, N.H. Moskowitz, M. Davis, C.B. Thompson, and S.L. Reiner. 1996. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184:803-810.
25. von Stebut, E., Y. Belkaid, T. Jakob, D.L. Sacks, and M.C. Udey. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188:1547-1552.
26. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159: 3838-3848.
27. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29: 1610-1616.
28. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592.
29. Weinberg, A.D., K.W. Wegmann, C. Funatake, and R.H. Whitham. 1999. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1818-1826.
30. Higgins, L.M., S.A. McDonald, N. Whittle, N. Crockett, J.G. Shields, and T.T. MacDonald. 1999. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162:486-493.